Skip to content

Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine

The Importance of Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine Before Renal Transplantation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03024229
Acronym
RENALIFE
Enrollment
40
Registered
2017-01-18
Start date
2017-03-15
Completion date
2020-01-14
Last updated
2025-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Transplantation

Keywords

Transplantation;perfusion machine

Brief summary

When the kidneys are perfused on perfusion machines before transplantation, the resistance parameters as well as the histological score on the pre-implantation biopsy participate in the evaluation of the quality of the graft. The metabolomic profile of the infusion fluid could provide additional evidence.

Detailed description

The quality of the renal transplant prior to transplantation is essential for the recovery of graft function in the days following transplantation and its long-term survival. When the kidneys are perfused on perfusion machines before transplantation, the resistance parameters as well as the histological score on the pre-implantation biopsy participate in the evaluation of the quality of the graft. The metabolomic profile of the infusion fluid could provide additional evidence.

Interventions

DEVICELifePort® perfusion machine

Renal perfusion on LifePort® machine

Sponsors

Laboratory of Biochemistry, University François Rabelais of TOURS
CollaboratorUNKNOWN
University Hospital, Tours
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Metabolic assessment in Urine and perfusion liquids

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Donors aged 18 years or more in brain death or who died of cardiac arrest collected locally in Tours, associated with the major local recipients of the grafts over the same period.

Exclusion criteria

* Kidney transplant removed but stored in a static preservative. * Kidney grafts of donors aged 18 years or more, removed and not retained on a LifePort® perfusion machine.

Design outcomes

Primary

MeasureTime frameDescription
IGF7 daysImmediate Graft Function (IGF), defined by serum creatinine less than 250 μM / L at day 7 post-kidney transplant, without requiring dialysis of the recipient patient.

Secondary

MeasureTime frameDescription
DGF7 daysDGF Delayed graft function : Dialysis need within 7 days post-transplant
BANFF-1PRE-OPERATIONALAnatomo-pathological classification of the pre-implantation biopsy according to the revised Banff classification 2013
BANFF-23 monthsAnatomo-pathological classification of systematic biopsy at 3 months post-transplant according to the revised Banff classification 2013

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026